Karina Tablet (Calidionogenase)

Adult dose

Administer 30~150I.U. orally in 3 divided doses. The dose may be adjusted according to age and symptoms.

This medication should not be used in patients with bleeding, such as cerebral hemorrhage. Additionally, this medication contains lactose and should not be administered to patients with genetically determined galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. While taking this medication, hypersensitivity symptoms such as skin rash or itching may appear; if such symptoms occur, administration should be immediately discontinued. Symptoms of rapid heart rate may also occur rarely, so caution is needed. Furthermore, gastrointestinal symptoms such as discomfort in the stomach, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may occur. Occasionally, symptoms such as a feeling of warmth, headache, heaviness in the head, drowsiness, or fatigue may also be experienced. Particularly in older individuals, the body's functions may be reduced, so careful administration, such as reducing the dose, should be exercised when using this medication.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. This ensures the drug's efficacy is maintained for a longer period and prevents deterioration.

Appearance

Green round enteric-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle